Indanorex
Indanorex (Dietor) is a stimulant drug which was developed in the 1970s. It has appetite suppressant effects and also has antihypoglycemia effects.[1]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C12H17NO |
Molar mass | 191.274 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
See also
References
- Giugliano D, Luyckx A, Binder D, Lefebvre P (February 1979). "Comparative effects of metformin and indanorex in the treatment of reactive hypoglycemia". International Journal of Clinical Pharmacology and Biopharmacy. 17 (2): 76–81. PMID 422305.
- Maillard, J. et al, Bull. Soc. Chim. Fr., 1967, 2110.
- Jacques Georges Maillard, U.S. Patent 3,885,045 (1975 to Logeais Labor Jacques).
- FR 2322851 (1977 to Logeais Labor Jacques).
DRAs |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRAs |
| ||||||||||||||
SRAs |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.